Table 1. Baseline characteristics of the cohort.
| Patient characteristics | Total (n = 1133) | HR-GNR colonized (n = 68) | HR-GNR not colonized (n = 1065) |
|---|---|---|---|
| Number of HR-GNR colonized patients | 68 (6.1) | 68 (100) | - |
| ESBL positive | 57 (5.0) | 57 (83.8) | - |
| Q&A positive | 13 (1.1) | 13 (19.1) | - |
| CPE positive | 1 (0.1) | 1 (1.5) | - |
| Other positive | 0 (0) | 0 (0) | - |
| Sex (male) | 553 (48.8) | 36 (52.9) | 517 (48.5) |
| ICU admission | 61 (5.4) | 6 (8.8) | 55 (5.2) |
| Used antibiotics 6 months before baseline | 223 (19.7) | 21 (30.9) | 202 (19.0) |
| Used antibiotics at baseline | 496 (43.8) | 37 (54.4) | 459 (43.1) |
| Admitted before baseline (up to 1 year) | 524 (46.2) | 43 (63.2) | 481 (45.2) |
| Earlier infection (up to two years before baseline) | 293 (25.9) | 35 (51.5) | 258 (24.2) |
| Mean age in years (SD) | 63.3 (22.9) | 68.2 (16.3) | 63.0 (23.2) |
| Median time from start admission to sampling in days (range) at baseline | 3.0 (0–74) | 5.5 (0–48) | 3 (0–74) |
Data are presented as numbers (%) unless indicated otherwise.
HR-GNR: Highly Resistant Gram-negative Rod; ESBL: extended spectrum beta lactamase; Q&A: Enterobacteriaceae resistant to fluoroquinolones and aminoglycosides; CPE: carbapenemase producing Enterobacteriaceae.